# GO_biological_process_0030: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_biological_process_0030.txt)

**Task:** `GO_biological_process`  
**Author key, unchanged:** **D** — mRNA splicing, via spliceosome

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSQSQVPSRAGHYNMTALANALPQANYRQAPWNNGSQMRYNPAGASPNVVGQTQSSPQYNGQPGMGSMPNQGYYMPQQQQQQQQMPQYYGGPMSPSQPQPNMSSRPNVPFYGNQVMSNHQAHPSMGYYYAQVPAYALQGHPPHQAPVDSQSNVVRGPPRKPRQSGHAIWIGNLPSQTDLMSLVHHVCREAQGLESLFLISKSNCAFANFRDEASCLTAQQKLHESKFQSVRLVSRLRKNTVEGASGITAPTGPSATTPQQAVAPEVKEIEQIDSTETQSDNADTDTPTAVGTPDAKGPAVVDAAQKDRFFVLKSLTVEDLDLSVRTGIWATQSHNEEALNSAFKNAENVYLVFSANKSGEYFGYARMVSTINEDPAAAIEFAPKAQSVNEVDLPREIPTEPTKFTPKGRIIDDSARGTIFWEIAREDSSEGVTQEEPAPAVAEQDDTTGGLDGNSENKTWGKPFKLEWLSTTRLPFYRCRGLRNPWNSNREVKIARDGTELEPSVGRRLIGLFNRSHNSPGPRGPMMGMGQMMSPSQQQMPMGYPPPYS

[Multiple Choices]
A. defense response to virus
B. AMP catabolic process
C. dTTP biosynthetic process
D. mRNA splicing, via spliceosome
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches a UniProt entry annotated with mRNA splicing via the spliceosome (D), but that GO annotation is computationally inferred (IEA:TreeGrafter), not direct experimental evidence of splicing. The cited experimental function concerns m6A-containing mRNA binding and stability, which supports an RNA-related role but does not specifically establish spliceosome-mediated splicing. The matching historical annotation supports the key as an annotation-based answer, with that limitation.

Citations as saved: [H4](#evidence-h4), [C6](#evidence-c6), [H3](#evidence-h3), [C5](#evidence-c5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is consistent with an RNA-related protein, making D more plausible than the virus-response, AMP-catabolism, or dTTP-biosynthesis choices. However, that broad inference does not establish the specific process of spliceosome-mediated mRNA splicing.


**Missing item-specific fact**

> A protein-specific functional characterization or annotation linking this sequence to spliceosomal mRNA splicing is needed to distinguish D from other possible RNA-related roles.


**Reason**

> The input provides only the sequence and choices. Selecting the specific GO process depends on item-specific annotation or experimental knowledge not supplied to the model; recognizing the sequence or recalling its database entry would be lookup or memorization.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> D is the only choice supported by the matching GO annotation. The experimental function excerpt does not establish D specifically, but it also does not support another listed option.


### Important caveats

- The sequence match is confirmed for the UniProt entry, but the author’s exact source snapshot is unknown.
- The spliceosome GO annotation is computationally inferred; the cited experimental function describes m6A-containing mRNA binding and stability, not direct spliceosome activity.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with an RNA-related protein, making D more plausible than the virus-response, AMP-catabolism, or dTTP-biosynthesis choices. However, that broad inference does not establish the specific process of spliceosome-mediated mRNA splicing.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "A protein-specific functional characterization or annotation linking this sequence to spliceosomal mRNA splicing is needed to distinguish D from other possible RNA-related roles.",
    "reason": "The input provides only the sequence and choices. Selecting the specific GO process depends on item-specific annotation or experimental knowledge not supplied to the model; recognizing the sequence or recalling its database entry would be lookup or memorization."
  },
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "evidence_ids": [
      "H4",
      "C6",
      "H3",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The sequence matches a UniProt entry annotated with mRNA splicing via the spliceosome (D), but that GO annotation is computationally inferred (IEA:TreeGrafter), not direct experimental evidence of splicing. The cited experimental function concerns m6A-containing mRNA binding and stability, which supports an RNA-related role but does not specifically establish spliceosome-mediated splicing. The matching historical annotation supports the key as an annotation-based answer, with that limitation."
  },
  "important_caveats": [
    "The sequence match is confirmed for the UniProt entry, but the author’s exact source snapshot is unknown.",
    "The spliceosome GO annotation is computationally inferred; the cited experimental function describes m6A-containing mRNA binding and stability, not direct spliceosome activity."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "D is the only choice supported by the matching GO annotation. The experimental function excerpt does not establish D specifically, but it also does not support another listed option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches a UniProt entry annotated with mRNA splicing via the spliceosome (D), but that GO annotation is computationally inferred (IEA:TreeGrafter), not direct experimental evidence of splicing. The cited experimental function concerns m6A-containing mRNA binding and stability, which supports an RNA-related role but does not specifically establish spliceosome-mediated splicing. The matching historical annotation supports the key as an annotation-based answer, with that limitation.",
    "evidence_ids": ["H4", "C6", "H3", "C5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is consistent with an RNA-related protein, making D more plausible than the virus-response, AMP-catabolism, or dTTP-biosynthesis choices. However, that broad inference does not establish the specific process of spliceosome-mediated mRNA splicing.",
    "missing_item_specific_fact": "A protein-specific functional characterization or annotation linking this sequence to spliceosomal mRNA splicing is needed to distinguish D from other possible RNA-related roles.",
    "reason": "The input provides only the sequence and choices. Selecting the specific GO process depends on item-specific annotation or experimental knowledge not supplied to the model; recognizing the sequence or recalling its database entry would be lookup or memorization."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "D is the only choice supported by the matching GO annotation. The experimental function excerpt does not establish D specifically, but it also does not support another listed option."
  },
  "important_caveats": [
    "The sequence match is confirmed for the UniProt entry, but the author’s exact source snapshot is unknown.",
    "The spliceosome GO annotation is computationally inferred; the cited experimental function describes m6A-containing mRNA binding and stability, not direct spliceosome activity."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (A0A9P4XWM4) annotates this protein with GO:0000398 'mRNA splicing, via spliceosome' (C6, H4) and GO:0000381 'regulation of alternative mRNA splicing, via spliceosome' (C7, H5). However, both annotations carry evidence code IEA:TreeGrafter, meaning they are computational inferences by automated similarity transfer, not experimental findings. The experimental evidence (ECO:0000269, PubMed:39159278) describes the protein as an m6A reader that regulates mRNA stability (C5, H3), not as a direct spliceosomal component. The annotation is present in the database, so the key is technically supported by the annotation record, but the supporting evidence is computational rather than experimental.

Citations as saved: [C6](#evidence-c6), [C7](#evidence-c7), [H4](#evidence-h4), [H5](#evidence-h5), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains features of an RNA-binding protein: low-complexity regions rich in Q, P, S, G residues (typical of intrinsically disordered RNA-binding domains) and no catalytic motifs for nucleotide metabolism (no kinase, phosphatase, or nucleotidyl-transferase signatures) and no antiviral effector domains (no OAS, PKR, or interferon-related motifs). Recognizing the YTH domain (a conserved m6A-reading fold) links the protein to mRNA processing/fate pathways. Among the four options, B (AMP catabolic process) and C (dTTP biosynthetic process) are nucleotide metabolism processes incompatible with an RNA-binding protein lacking any enzymatic catalytic machinery for nucleotide interconversion. A (defense response to virus) has no supporting sequence features. D (mRNA splicing, via spliceosome) is the only option in the mRNA-processing space, making it the best match by elimination and by the general association of YTH-domain proteins with mRNA maturation and fate.


**Missing item-specific fact**

> The specific experimental evidence for this protein describes m6A-dependent mRNA stability regulation, not direct spliceosomal splicing. The assignment to 'mRNA splicing, via spliceosome' specifically (rather than 'mRNA stability' or 'mRNA processing') relies on the IEA:TreeGrafter computational annotation, which is not derivable from the sequence alone without recognizing the exact YTHDF1 ortholog and its database annotation.


**Reason**

> The question is answerable by elimination and general biological reasoning: the sequence is clearly an RNA-binding protein (not a nucleotide-metabolism enzyme or antiviral effector), and D is the only mRNA-processing option. However, the precise mapping to 'splicing via spliceosome' rather than 'mRNA stability' depends on the specific database annotation (IEA), which is a computational inference not derivable from the sequence features alone. The reasoning path is supported but somewhat indirect.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C are clearly incompatible with an RNA-binding protein lacking nucleotide-metabolism or antiviral-effector domains. D is the only mRNA-processing option. While the experimental function (m6A-dependent mRNA stability) is not identical to 'mRNA splicing, via spliceosome,' no better option exists among the four choices, so D is uniquely defensible within the given option set.


### Important caveats

- The GO annotation for 'mRNA splicing, via spliceosome' is IEA:TreeGrafter (automated computational transfer), not experimental. The experimental evidence (PubMed:39159278) describes m6A reading and mRNA stability, not direct spliceosomal activity.
- The protein is a YTH-domain m6A reader (YTHDF1 ortholog in Cryphonectria parasitica). While m6A modifications can influence splicing decisions, this protein's experimentally demonstrated role is mRNA stability regulation, not catalysis of spliceosomal splicing.
- The sequence match is confirmed (SHA256 identical between benchmark and UniProt entry), so the annotation applies to the exact sequence presented.
- The benchmark question asks for the 'primary biological process,' and the IEA annotation may not reflect the most accurate or primary process for this protein based on available experimental data.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains features of an RNA-binding protein: low-complexity regions rich in Q, P, S, G residues (typical of intrinsically disordered RNA-binding domains) and no catalytic motifs for nucleotide metabolism (no kinase, phosphatase, or nucleotidyl-transferase signatures) and no antiviral effector domains (no OAS, PKR, or interferon-related motifs). Recognizing the YTH domain (a conserved m6A-reading fold) links the protein to mRNA processing/fate pathways. Among the four options, B (AMP catabolic process) and C (dTTP biosynthetic process) are nucleotide metabolism processes incompatible with an RNA-binding protein lacking any enzymatic catalytic machinery for nucleotide interconversion. A (defense response to virus) has no supporting sequence features. D (mRNA splicing, via spliceosome) is the only option in the mRNA-processing space, making it the best match by elimination and by the general association of YTH-domain proteins with mRNA maturation and fate.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The specific experimental evidence for this protein describes m6A-dependent mRNA stability regulation, not direct spliceosomal splicing. The assignment to 'mRNA splicing, via spliceosome' specifically (rather than 'mRNA stability' or 'mRNA processing') relies on the IEA:TreeGrafter computational annotation, which is not derivable from the sequence alone without recognizing the exact YTHDF1 ortholog and its database annotation.",
    "reason": "The question is answerable by elimination and general biological reasoning: the sequence is clearly an RNA-binding protein (not a nucleotide-metabolism enzyme or antiviral effector), and D is the only mRNA-processing option. However, the precise mapping to 'splicing via spliceosome' rather than 'mRNA stability' depends on the specific database annotation (IEA), which is a computational inference not derivable from the sequence features alone. The reasoning path is supported but somewhat indirect."
  },
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "C7",
      "H4",
      "H5",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (A0A9P4XWM4) annotates this protein with GO:0000398 'mRNA splicing, via spliceosome' (C6, H4) and GO:0000381 'regulation of alternative mRNA splicing, via spliceosome' (C7, H5). However, both annotations carry evidence code IEA:TreeGrafter, meaning they are computational inferences by automated similarity transfer, not experimental findings. The experimental evidence (ECO:0000269, PubMed:39159278) describes the protein as an m6A reader that regulates mRNA stability (C5, H3), not as a direct spliceosomal component. The annotation is present in the database, so the key is technically supported by the annotation record, but the supporting evidence is computational rather than experimental."
  },
  "important_caveats": [
    "The GO annotation for 'mRNA splicing, via spliceosome' is IEA:TreeGrafter (automated computational transfer), not experimental. The experimental evidence (PubMed:39159278) describes m6A reading and mRNA stability, not direct spliceosomal activity.",
    "The protein is a YTH-domain m6A reader (YTHDF1 ortholog in Cryphonectria parasitica). While m6A modifications can influence splicing decisions, this protein's experimentally demonstrated role is mRNA stability regulation, not catalysis of spliceosomal splicing.",
    "The sequence match is confirmed (SHA256 identical between benchmark and UniProt entry), so the annotation applies to the exact sequence presented.",
    "The benchmark question asks for the 'primary biological process,' and the IEA annotation may not reflect the most accurate or primary process for this protein based on available experimental data."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly incompatible with an RNA-binding protein lacking nucleotide-metabolism or antiviral-effector domains. D is the only mRNA-processing option. While the experimental function (m6A-dependent mRNA stability) is not identical to 'mRNA splicing, via spliceosome,' no better option exists among the four choices, so D is uniquely defensible within the given option set."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (A0A9P4XWM4) annotates this protein with GO:0000398 'mRNA splicing, via spliceosome' (C6, H4) and GO:0000381 'regulation of alternative mRNA splicing, via spliceosome' (C7, H5). However, both annotations carry evidence code IEA:TreeGrafter, meaning they are computational inferences by automated similarity transfer, not experimental findings. The experimental evidence (ECO:0000269, PubMed:39159278) describes the protein as an m6A reader that regulates mRNA stability (C5, H3), not as a direct spliceosomal component. The annotation is present in the database, so the key is technically supported by the annotation record, but the supporting evidence is computational rather than experimental.",
    "evidence_ids": ["C6", "C7", "H4", "H5", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains features of an RNA-binding protein: low-complexity regions rich in Q, P, S, G residues (typical of intrinsically disordered RNA-binding domains) and no catalytic motifs for nucleotide metabolism (no kinase, phosphatase, or nucleotidyl-transferase signatures) and no antiviral effector domains (no OAS, PKR, or interferon-related motifs). Recognizing the YTH domain (a conserved m6A-reading fold) links the protein to mRNA processing/fate pathways. Among the four options, B (AMP catabolic process) and C (dTTP biosynthetic process) are nucleotide metabolism processes incompatible with an RNA-binding protein lacking any enzymatic catalytic machinery for nucleotide interconversion. A (defense response to virus) has no supporting sequence features. D (mRNA splicing, via spliceosome) is the only option in the mRNA-processing space, making it the best match by elimination and by the general association of YTH-domain proteins with mRNA maturation and fate.",
    "missing_item_specific_fact": "The specific experimental evidence for this protein describes m6A-dependent mRNA stability regulation, not direct spliceosomal splicing. The assignment to 'mRNA splicing, via spliceosome' specifically (rather than 'mRNA stability' or 'mRNA processing') relies on the IEA:TreeGrafter computational annotation, which is not derivable from the sequence alone without recognizing the exact YTHDF1 ortholog and its database annotation.",
    "reason": "The question is answerable by elimination and general biological reasoning: the sequence is clearly an RNA-binding protein (not a nucleotide-metabolism enzyme or antiviral effector), and D is the only mRNA-processing option. However, the precise mapping to 'splicing via spliceosome' rather than 'mRNA stability' depends on the specific database annotation (IEA), which is a computational inference not derivable from the sequence features alone. The reasoning path is supported but somewhat indirect."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly incompatible with an RNA-binding protein lacking nucleotide-metabolism or antiviral-effector domains. D is the only mRNA-processing option. While the experimental function (m6A-dependent mRNA stability) is not identical to 'mRNA splicing, via spliceosome,' no better option exists among the four choices, so D is uniquely defensible within the given option set."
  },
  "important_caveats": [
    "The GO annotation for 'mRNA splicing, via spliceosome' is IEA:TreeGrafter (automated computational transfer), not experimental. The experimental evidence (PubMed:39159278) describes m6A reading and mRNA stability, not direct spliceosomal activity.",
    "The protein is a YTH-domain m6A reader (YTHDF1 ortholog in Cryphonectria parasitica). While m6A modifications can influence splicing decisions, this protein's experimentally demonstrated role is mRNA stability regulation, not catalysis of spliceosomal splicing.",
    "The sequence match is confirmed (SHA256 identical between benchmark and UniProt entry), so the annotation applies to the exact sequence presented.",
    "The benchmark question asks for the 'primary biological process,' and the IEA annotation may not reflect the most accurate or primary process for this protein based on available experimental data."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The matched sequence has a UniProt GO annotation for mRNA splicing via the spliceosome, but its evidence code is IEA:TreeGrafter, a computational annotation rather than direct experimental evidence. The reported experimental function concerns m6A-containing mRNA binding and regulation of mRNA stability, which supports an RNA-processing role broadly but does not independently establish spliceosome-mediated splicing.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is consistent with a YTH-domain RNA-binding protein. Transferable knowledge about this protein family links YTH proteins to mRNA recognition and post-transcriptional RNA regulation. Among these choices, mRNA splicing is the RNA-processing option; the other choices describe antiviral defense or nucleotide metabolism. This supports D as the best fit among the offered alternatives, though the family feature alone does not specifically prove spliceosome involvement.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A family-level RNA-processing inference meaningfully favors D over the unrelated biological processes offered. The exact spliceosomal annotation is not recoverable with certainty from the sequence alone, but that limitation does not prevent a credible choice among these alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> No other offered option has comparable support from the RNA-binding protein sequence context.


### Important caveats

- The direct GO support for D is computational; the supplied experimental function supports mRNA regulation and processing broadly, not specifically spliceosome-mediated splicing.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a YTH-domain RNA-binding protein. Transferable knowledge about this protein family links YTH proteins to mRNA recognition and post-transcriptional RNA regulation. Among these choices, mRNA splicing is the RNA-processing option; the other choices describe antiviral defense or nucleotide metabolism. This supports D as the best fit among the offered alternatives, though the family feature alone does not specifically prove spliceosome involvement.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A family-level RNA-processing inference meaningfully favors D over the unrelated biological processes offered. The exact spliceosomal annotation is not recoverable with certainty from the sequence alone, but that limitation does not prevent a credible choice among these alternatives."
  },
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The matched sequence has a UniProt GO annotation for mRNA splicing via the spliceosome, but its evidence code is IEA:TreeGrafter, a computational annotation rather than direct experimental evidence. The reported experimental function concerns m6A-containing mRNA binding and regulation of mRNA stability, which supports an RNA-processing role broadly but does not independently establish spliceosome-mediated splicing."
  },
  "important_caveats": [
    "The direct GO support for D is computational; the supplied experimental function supports mRNA regulation and processing broadly, not specifically spliceosome-mediated splicing."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No other offered option has comparable support from the RNA-binding protein sequence context."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched sequence has a UniProt GO annotation for mRNA splicing via the spliceosome, but its evidence code is IEA:TreeGrafter, a computational annotation rather than direct experimental evidence. The reported experimental function concerns m6A-containing mRNA binding and regulation of mRNA stability, which supports an RNA-processing role broadly but does not independently establish spliceosome-mediated splicing.",
    "evidence_ids": ["C5", "C6", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is consistent with a YTH-domain RNA-binding protein. Transferable knowledge about this protein family links YTH proteins to mRNA recognition and post-transcriptional RNA regulation. Among these choices, mRNA splicing is the RNA-processing option; the other choices describe antiviral defense or nucleotide metabolism. This supports D as the best fit among the offered alternatives, though the family feature alone does not specifically prove spliceosome involvement.",
    "missing_item_specific_fact": "",
    "reason": "A family-level RNA-processing inference meaningfully favors D over the unrelated biological processes offered. The exact spliceosomal annotation is not recoverable with certainty from the sequence alone, but that limitation does not prevent a credible choice among these alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "No other offered option has comparable support from the RNA-binding protein sequence context."
  },
  "important_caveats": [
    "The direct GO support for D is computational; the supplied experimental function supports mRNA regulation and processing broadly, not specifically spliceosome-mediated splicing."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A9P4XWM4, YTH1_CRYP1) carries GO:0000398 'mRNA splicing, via spliceosome' as an annotation, matching option D. However, the evidence code is IEA:TreeGrafter (computational inference by homology), not experimental. The experimentally validated function (ECO:0000269, PubMed:39159278) describes m6A recognition and mRNA stability regulation, which is related to mRNA processing but is not specifically spliceosomal splicing. The annotation is present in the database and thus technically supports the key, but the evidence quality is low (IEA-level computational transfer rather than direct experimental demonstration of spliceosomal splicing activity).

Citations as saved: [C6](#evidence-c6), [C7](#evidence-c7), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains features consistent with a YTH domain RNA-binding protein: low-complexity N- and C-terminal regions (poly-Q, poly-P stretches) flanking a structured middle region with conserved aromatic residues (tryptophans) characteristic of the YTH aromatic cage that binds m6A. A model familiar with YTH domain proteins (YTHDF1/2/3, YTHDC1/2 in metazoans, and fungal homologs) would recognize these as mRNA-binding/processing factors. Among the four choices, A (defense response to virus) relates to innate immune signaling, B (AMP catabolic process) and C (dTTP biosynthetic process) are nucleotide-metabolism enzyme functions—none of which involve RNA-binding domains or the structural architecture seen here. Only D (mRNA splicing, via spliceosome) falls within the mRNA-processing/metabolism space that a YTH-domain protein inhabits. Thus, family-level recognition of the YTH domain plus elimination of three mechanistically unrelated options meaningfully distinguishes D. The inference is probabilistic (YTH proteins are primarily m6A readers affecting stability and sometimes splicing, not direct spliceosome catalytic components), but among the offered alternatives D is the only one in the correct functional neighborhood.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A model can use transferable knowledge of YTH domain architecture (aromatic cage tryptophans, low-complexity flanking regions, ~500-aa protein length) to identify the protein as an mRNA-binding/processing factor, then eliminate A, B, and C as mechanistically unrelated (viral defense, AMP catabolism, dTTP synthesis). This family-level inference plus elimination logic distinguishes D without requiring recall of this specific protein's database record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C describe processes (antiviral defense, AMP catabolism, dTTP biosynthesis) that are mechanistically incompatible with an RNA-binding protein bearing a YTH domain. Only D is in the mRNA-processing space. While the precise sub-process (spliceosomal splicing vs. mRNA stability/processing) could be debated for a YTH m6A reader, no other offered option is defensible.


### Important caveats

- The GO:0000398 annotation carries IEA:TreeGrafter evidence (computational homology transfer), not experimental proof of spliceosomal splicing activity for this protein.
- The experimentally validated function is m6A recognition and mRNA stability regulation, which is a sibling/parent concept to 'mRNA splicing, via spliceosome' under 'mRNA processing' but not identical to it.
- The protein is from a fungal pathogen (Cryphonectria parasitica); YTH domain biology in fungi is less characterized than in metazoans, adding uncertainty to the precise GO assignment.
- The sequence-to-annotation link was established by reviewer-only accession lookup; the evaluated model saw only the raw sequence and four options.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains features consistent with a YTH domain RNA-binding protein: low-complexity N- and C-terminal regions (poly-Q, poly-P stretches) flanking a structured middle region with conserved aromatic residues (tryptophans) characteristic of the YTH aromatic cage that binds m6A. A model familiar with YTH domain proteins (YTHDF1/2/3, YTHDC1/2 in metazoans, and fungal homologs) would recognize these as mRNA-binding/processing factors. Among the four choices, A (defense response to virus) relates to innate immune signaling, B (AMP catabolic process) and C (dTTP biosynthetic process) are nucleotide-metabolism enzyme functions—none of which involve RNA-binding domains or the structural architecture seen here. Only D (mRNA splicing, via spliceosome) falls within the mRNA-processing/metabolism space that a YTH-domain protein inhabits. Thus, family-level recognition of the YTH domain plus elimination of three mechanistically unrelated options meaningfully distinguishes D. The inference is probabilistic (YTH proteins are primarily m6A readers affecting stability and sometimes splicing, not direct spliceosome catalytic components), but among the offered alternatives D is the only one in the correct functional neighborhood.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A model can use transferable knowledge of YTH domain architecture (aromatic cage tryptophans, low-complexity flanking regions, ~500-aa protein length) to identify the protein as an mRNA-binding/processing factor, then eliminate A, B, and C as mechanistically unrelated (viral defense, AMP catabolism, dTTP synthesis). This family-level inference plus elimination logic distinguishes D without requiring recall of this specific protein's database record."
  },
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "evidence_ids": [
      "C6",
      "C7",
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A9P4XWM4, YTH1_CRYP1) carries GO:0000398 'mRNA splicing, via spliceosome' as an annotation, matching option D. However, the evidence code is IEA:TreeGrafter (computational inference by homology), not experimental. The experimentally validated function (ECO:0000269, PubMed:39159278) describes m6A recognition and mRNA stability regulation, which is related to mRNA processing but is not specifically spliceosomal splicing. The annotation is present in the database and thus technically supports the key, but the evidence quality is low (IEA-level computational transfer rather than direct experimental demonstration of spliceosomal splicing activity)."
  },
  "important_caveats": [
    "The GO:0000398 annotation carries IEA:TreeGrafter evidence (computational homology transfer), not experimental proof of spliceosomal splicing activity for this protein.",
    "The experimentally validated function is m6A recognition and mRNA stability regulation, which is a sibling/parent concept to 'mRNA splicing, via spliceosome' under 'mRNA processing' but not identical to it.",
    "The protein is from a fungal pathogen (Cryphonectria parasitica); YTH domain biology in fungi is less characterized than in metazoans, adding uncertainty to the precise GO assignment.",
    "The sequence-to-annotation link was established by reviewer-only accession lookup; the evaluated model saw only the raw sequence and four options."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C describe processes (antiviral defense, AMP catabolism, dTTP biosynthesis) that are mechanistically incompatible with an RNA-binding protein bearing a YTH domain. Only D is in the mRNA-processing space. While the precise sub-process (spliceosomal splicing vs. mRNA stability/processing) could be debated for a YTH m6A reader, no other offered option is defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0030",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A9P4XWM4, YTH1_CRYP1) carries GO:0000398 'mRNA splicing, via spliceosome' as an annotation, matching option D. However, the evidence code is IEA:TreeGrafter (computational inference by homology), not experimental. The experimentally validated function (ECO:0000269, PubMed:39159278) describes m6A recognition and mRNA stability regulation, which is related to mRNA processing but is not specifically spliceosomal splicing. The annotation is present in the database and thus technically supports the key, but the evidence quality is low (IEA-level computational transfer rather than direct experimental demonstration of spliceosomal splicing activity).",
    "evidence_ids": ["C6", "C7", "C5", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains features consistent with a YTH domain RNA-binding protein: low-complexity N- and C-terminal regions (poly-Q, poly-P stretches) flanking a structured middle region with conserved aromatic residues (tryptophans) characteristic of the YTH aromatic cage that binds m6A. A model familiar with YTH domain proteins (YTHDF1/2/3, YTHDC1/2 in metazoans, and fungal homologs) would recognize these as mRNA-binding/processing factors. Among the four choices, A (defense response to virus) relates to innate immune signaling, B (AMP catabolic process) and C (dTTP biosynthetic process) are nucleotide-metabolism enzyme functions—none of which involve RNA-binding domains or the structural architecture seen here. Only D (mRNA splicing, via spliceosome) falls within the mRNA-processing/metabolism space that a YTH-domain protein inhabits. Thus, family-level recognition of the YTH domain plus elimination of three mechanistically unrelated options meaningfully distinguishes D. The inference is probabilistic (YTH proteins are primarily m6A readers affecting stability and sometimes splicing, not direct spliceosome catalytic components), but among the offered alternatives D is the only one in the correct functional neighborhood.",
    "missing_item_specific_fact": "",
    "reason": "A model can use transferable knowledge of YTH domain architecture (aromatic cage tryptophans, low-complexity flanking regions, ~500-aa protein length) to identify the protein as an mRNA-binding/processing factor, then eliminate A, B, and C as mechanistically unrelated (viral defense, AMP catabolism, dTTP synthesis). This family-level inference plus elimination logic distinguishes D without requiring recall of this specific protein's database record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C describe processes (antiviral defense, AMP catabolism, dTTP biosynthesis) that are mechanistically incompatible with an RNA-binding protein bearing a YTH domain. Only D is in the mRNA-processing space. While the precise sub-process (spliceosomal splicing vs. mRNA stability/processing) could be debated for a YTH m6A reader, no other offered option is defensible."
  },
  "important_caveats": [
    "The GO:0000398 annotation carries IEA:TreeGrafter evidence (computational homology transfer), not experimental proof of spliceosomal splicing activity for this protein.",
    "The experimentally validated function is m6A recognition and mRNA stability regulation, which is a sibling/parent concept to 'mRNA splicing, via spliceosome' under 'mRNA processing' but not identical to it.",
    "The protein is from a fungal pathogen (Cryphonectria parasitica); YTH domain biology in fungi is less characterized than in metazoans, adding uncertainty to the precise GO assignment.",
    "The sequence-to-annotation link was established by reviewer-only accession lookup; the evaluated model saw only the raw sequence and four options."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A9P4XWM4",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "9bc16b617f164832ddc73de3c0ad6682c3eeb589f7911dde78dbb48cc5f073c4",
  "benchmark_sequence_length": 549,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 10,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-06-10",
    "lastSequenceUpdateDate": "2023-09-13",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "current_source_sequence_sha256": "9bc16b617f164832ddc73de3c0ad6682c3eeb589f7911dde78dbb48cc5f073c4",
  "current_source_sequence_length": 549,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 9,
  "selected_historical_version": {
    "accession": "A0A9P4XWM4",
    "database": "Swiss-Prot",
    "entryVersion": 9,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "YTH1_CRYP1",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "c3b8596e9f966d9f9550fbc6c24f4aadbf3af136cfbef9ec39bac6ceeb6c8c94",
  "selected_historical_source_sequence_sha256": "9bc16b617f164832ddc73de3c0ad6682c3eeb589f7911dde78dbb48cc5f073c4",
  "selected_historical_source_sequence_length": 549,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 9,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A9P4XWM4\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":10,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-06-10\",\"lastSequenceUpdateDate\":\"2023-09-13\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Sordariomycetidae\",\"Diaporthales\",\"Cryphonectriaceae\",\"Cryphonectria-Endothia species complex\",\"Cryphonectria\"],\"scientificName\":\"Cryphonectria parasitica (strain ATCC 38755 / EP155)\",\"taxonId\":660469}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39159278\",\"source\":\"PubMed\"}],\"value\":\"M6A reader YTH1\"}}],\"recommendedName\":{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39159278\",\"source\":\"PubMed\"}],\"value\":\"YTH domain-containing family protein 1\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39159278\",\"source\":\"PubMed\"}],\"value\":\"Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, and regulates their stability (PubMed:39159278). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed:39159278). Directly interacts with the acid phosphatase APHA mRNA to increase its stability (PubMed:39159278)\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/uniProtKBCrossReferences/8",
  "excerpt": "{\"database\":\"GO\",\"id\":\"GO:0000398\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"P:mRNA splicing, via spliceosome\"},{\"key\":\"GoEvidenceType\",\"value\":\"IEA:TreeGrafter\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/uniProtKBCrossReferences/9",
  "excerpt": "{\"database\":\"GO\",\"id\":\"GO:0000381\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"P:regulation of alternative mRNA splicing, via spliceosome\"},{\"key\":\"GoEvidenceType\",\"value\":\"IEA:TreeGrafter\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A9P4XWM4.json",
  "source_sha256": "db50baf2da9c3578bbb0fd65f314e65acd497ae93fff839d779dccedf824beb7",
  "retrieved_utc": "2026-11-02T04:26:16.400481+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Zhao L.\",\"Wei X.\",\"Chen F.\",\"Yuan L.\",\"Chen B.\",\"Li R.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39159278\"},{\"database\":\"DOI\",\"id\":\"10.1371/journal.ppat.1012476\"}],\"citationType\":\"journal article\",\"firstPage\":\"e1012476\",\"id\":\"39159278\",\"journal\":\"PLoS Pathog.\",\"lastPage\":\"e1012476\",\"publicationDate\":\"2024\",\"title\":\"N6-methyladenosine RNA methyltransferase CpMTA1 mediates CpAphA mRNA stability through a YTHDF1-dependent m6A modification in the chestnut blight fungus.\",\"volume\":\"20\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"DISRUPTION PHENOTYPE\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9",
  "source_sha256": "c3b8596e9f966d9f9550fbc6c24f4aadbf3af136cfbef9ec39bac6ceeb6c8c94",
  "retrieved_utc": "2026-11-02T04:26:18.939090+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   YTH1_CRYP1              Reviewed;         549 AA.\nAC   A0A9P4XWM4;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   13-SEP-2023, sequence version 1.\nDT   28-JAN-2026, entry version 9.\nDE   RecName: Full=YTH domain-containing family protein 1 {ECO:0000303|PubMed:39159278};\nDE   AltName: Full=M6A reader YTH1 {ECO:0000303|PubMed:39159278};\nGN   Name=YTH1 {ECO:0000303|PubMed:39159278}; ORFNames=M406DRAFT_352687;\nOS   Cryphonectria parasitica (strain ATCC 38755 / EP155).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Sordariomycetidae; Diaporthales; Cryphonectriaceae;\nOC   Cryphonectria-Endothia species complex; Cryphonectria.\nOX   NCBI_TaxID=660469;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 9,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9",
  "source_sha256": "c3b8596e9f966d9f9550fbc6c24f4aadbf3af136cfbef9ec39bac6ceeb6c8c94",
  "retrieved_utc": "2026-11-02T04:26:18.939090+00:00",
  "source_locator": "lines 25-32",
  "excerpt": "RN   [2]\nRP   FUNCTION, AND DISRUPTION PHENOTYPE.\nRX   PubMed=39159278; DOI=10.1371/journal.ppat.1012476;\nRA   Zhao L., Wei X., Chen F., Yuan L., Chen B., Li R.;\nRT   \"N6-methyladenosine RNA methyltransferase CpMTA1 mediates CpAphA mRNA\nRT   stability through a YTHDF1-dependent m6A modification in the chestnut\nRT   blight fungus.\";\nRL   PLoS Pathog. 20:e1012476-e1012476(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 9,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9",
  "source_sha256": "c3b8596e9f966d9f9550fbc6c24f4aadbf3af136cfbef9ec39bac6ceeb6c8c94",
  "retrieved_utc": "2026-11-02T04:26:18.939090+00:00",
  "source_locator": "lines 33-39",
  "excerpt": "CC   -!- FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-\nCC       containing mRNAs, and regulates their stability (PubMed:39159278). M6A\nCC       is a modification present at internal sites of mRNAs and some non-\nCC       coding RNAs and plays a role in mRNA stability and processing\nCC       (PubMed:39159278). Directly interacts with the acid phosphatase APHA\nCC       mRNA to increase its stability (PubMed:39159278).\nCC       {ECO:0000269|PubMed:39159278}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 9,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9",
  "source_sha256": "c3b8596e9f966d9f9550fbc6c24f4aadbf3af136cfbef9ec39bac6ceeb6c8c94",
  "retrieved_utc": "2026-11-02T04:26:18.939090+00:00",
  "source_locator": "lines 56-56",
  "excerpt": "DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IEA:TreeGrafter.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 9,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A9P4XWM4?format=txt&versions=9",
  "source_sha256": "c3b8596e9f966d9f9550fbc6c24f4aadbf3af136cfbef9ec39bac6ceeb6c8c94",
  "retrieved_utc": "2026-11-02T04:26:18.939090+00:00",
  "source_locator": "lines 57-57",
  "excerpt": "DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:TreeGrafter.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 9,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 4085-4104",
  "excerpt": "[Term]\nid: GO:0000398\nname: mRNA splicing, via spliceosome\nnamespace: biological_process\nalt_id: GO:0006374\nalt_id: GO:0006375\ndef: \"The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.\" [GOC:krc, ISBN:0198506732, ISBN:0879695897]\ncomment: Note that although the many U12-type introns have the sequence AT-AC at the intron termini, some introns with these terminal sequences are spliced by the U2-type spliceosome. The distinguishing characteristics are sequences near the 5' splice site and the branch point sequences of the intron. Note that although the majority of U2-type introns have the sequence GU-AG at the intron termini, some introns with these terminal sequences are spliced by the U12-type spliceosome. The distinguishing characteristics are sequences near the 5' splice site and the branch point sequences of the intron.\nsynonym: \"mRNA splicing\" BROAD []\nsynonym: \"nuclear mRNA splicing via U12-type spliceosome\" NARROW []\nsynonym: \"nuclear mRNA splicing via U2-type spliceosome\" NARROW []\nsynonym: \"nuclear mRNA splicing, via spliceosome\" EXACT [GOC:krc, GOC:vw]\nsynonym: \"pre-mRNA splicing\" BROAD []\nsynonym: \"splicing AT-AC intron\" RELATED []\nsynonym: \"splicing GT-AG intron\" RELATED []\nxref: Reactome:R-HSA-72163 \"mRNA Splicing - Major Pathway\"\nxref: Reactome:R-HSA-72165 \"mRNA Splicing - Minor Pathway\"\nis_a: GO:0000377 ! RNA splicing, via transesterification reactions with bulged adenosine as nucleophile\nis_a: GO:0006397 ! mRNA processing\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0000398"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 63799-63810",
  "excerpt": "[Term]\nid: GO:0006196\nname: AMP catabolic process\nnamespace: biological_process\ndef: \"The chemical reactions and pathways resulting in the breakdown of AMP, adenosine monophosphate.\" [ISBN:0198506732]\nsynonym: \"AMP breakdown\" EXACT []\nsynonym: \"AMP catabolism\" EXACT []\nsynonym: \"AMP degradation\" EXACT []\nis_a: GO:0009154 ! purine ribonucleotide catabolic process\nis_a: GO:0009169 ! purine ribonucleoside monophosphate catabolic process\nis_a: GO:0046033 ! AMP metabolic process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0006196"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 64263-64276",
  "excerpt": "[Term]\nid: GO:0006235\nname: dTTP biosynthetic process\nnamespace: biological_process\ndef: \"The chemical reactions and pathways resulting in the formation of dTTP, deoxyribosylthymine triphosphate.\" [ISBN:0198506732]\nsynonym: \"dTTP anabolism\" EXACT []\nsynonym: \"dTTP biosynthesis\" EXACT []\nsynonym: \"dTTP formation\" EXACT []\nsynonym: \"dTTP synthesis\" EXACT []\nis_a: GO:0009202 ! deoxyribonucleoside triphosphate biosynthetic process\nis_a: GO:0009212 ! pyrimidine deoxyribonucleoside triphosphate biosynthetic process\nis_a: GO:0009221 ! pyrimidine deoxyribonucleotide biosynthetic process\nis_a: GO:0046075 ! dTTP metabolic process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0006235"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 328631-328642",
  "excerpt": "[Term]\nid: GO:0051607\nname: defense response to virus\nnamespace: biological_process\ndef: \"Reactions triggered in response to the presence of a virus that act to protect the cell or organism.\" [GOC:ai]\nsynonym: \"antiviral response\" EXACT []\nsynonym: \"defence response to virus\" EXACT []\nsynonym: \"defense response to viruses\" EXACT []\nxref: Reactome:R-HSA-8983711 \"OAS antiviral response\"\nis_a: GO:0006952 ! defense response\nis_a: GO:0009615 ! response to virus\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0051607"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 30. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
